The store will not work correctly when cookies are disabled.
6-(2-isopropoxyphenyl)-1-phenyl-5H-pyrazolo[3,4-d]pyrimidin-4-one
ID: ALA4788014
PubChem CID: 162668597
Max Phase: Preclinical
Molecular Formula: C20H18N4O2
Molecular Weight: 346.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Oc1ccccc1-c1nc2c(cnn2-c2ccccc2)c(=O)[nH]1
Standard InChI: InChI=1S/C20H18N4O2/c1-13(2)26-17-11-7-6-10-15(17)18-22-19-16(20(25)23-18)12-21-24(19)14-8-4-3-5-9-14/h3-13H,1-2H3,(H,22,23,25)
Standard InChI Key: BPBQNQUKBPQXJY-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
21.7640 -4.9992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4767 -4.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1856 -4.9986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1856 -5.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4751 -6.2286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7640 -5.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.9799 -6.0780 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4966 -5.4119 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.9799 -4.7418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7652 -6.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3477 -7.4540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1371 -8.2518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3395 -8.4624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7593 -7.8855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9671 -7.0870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8980 -6.2320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6107 -5.8196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3236 -6.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3236 -7.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6132 -7.4685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8980 -7.0580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6107 -4.9945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.3231 -4.5820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3231 -3.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0396 -4.9945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4767 -3.7642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 2 0
6 5 1 0
1 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
1 9 1 0
10 7 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
16 4 1 0
17 16 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
16 21 1 0
17 22 1 0
22 23 1 0
23 24 1 0
23 25 1 0
2 26 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 346.39 | Molecular Weight (Monoisotopic): 346.1430 | AlogP: 3.56 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.80 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.88 | CX Basic pKa: ┄ | CX LogP: 3.42 | CX LogD: 3.41 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.61 | Np Likeness Score: -1.61 |
References
1. Shaaban MA,Elshaier YAMM,Hammad AH,Farag NA,Hassan Haredy H,AbdEl-Ghany AA,Mohamed KO. (2020) Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors., 30 (16): [PMID:32631538] [10.1016/j.bmcl.2020.127337] |